1. Shields P., Glembotski C. (1989): Regulation of atrial natriuretic factor-secretion from neonatal rat primary atrial cultures by activators of protein kinases A and C. Biol. Chem. 264, 9322–9328
2. Hollenberg M., Plum J, Heering P., Heering P., Kutkuthn H.B., Grabensee B (1991): Influence of betaxolol on renal function and atrial natriuretic peptide in essential hypertension. J. Hypertension 9, 819–824
3. Papadopoulos C.L., Kokkas B., Kotridis P., Kanonidis I., Kyriakou P., Poulntzas N., Kotoula M., Kouvelas D., Sabbatis S., Sakadamis G., Paradelis A. (1992). The long-term effect of β1-blocker bisoprolol on blood pressure and atrial natriuretic peptide plasma levels in hypertensive patients after. Arterial Hypertension (Greek) 1, 201–205
4. Papadopoulos C.L., Kokkas B., Kotridis P., Gitsios C., Sakadamis G., Kanonides I., Kotoula M., Paradelis A. (1995): The effect of β1-blocker bisoprolol on atrial natriuretic peptide plasma levels in hypertensive patients. Intern. J. Angiology 4, 165–168
5. Hama J., Nagata S., Takenaka T., Kino S., Shimada M., Horiuchi M., Katori R. (1995): Atrial natriuretic peptide and antihypertensive action due to beta-blockade in essential hypertensive patients. Angiology 46, 511–516